What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
His primary scientific interests are in Pathology, Apoptosis, Sepsis, Immunohistochemistry and Immunology.
His biological study spans a wide range of topics, including Carcinoembryonic antigen and Adenocarcinoma.
His research integrates issues of Cell and Kinase activity in his study of Apoptosis.
His Sepsis study combines topics from a wide range of disciplines, such as Inflammation, T cell, Epithelium and Pathogenesis.
The Immunohistochemistry study combines topics in areas such as Larynx and Fibromatosis.
His Immunology research focuses on Prospective cohort study and how it connects with Critically ill, CD8 and Immunosuppression.
His most cited work include:
- IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity (2127 citations)
- Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction (1045 citations)
- Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. (661 citations)
What are the main themes of his work throughout his whole career to date?
Pathology, Immunohistochemistry, Carcinoma, Apoptosis and Sepsis are his primary areas of study.
His studies in Pathology integrate themes in fields like Internal medicine and Adenocarcinoma.
His Immunohistochemistry research focuses on subjects like Medical physics, which are linked to Precision medicine.
His Carcinoma study integrates concerns from other disciplines, such as Prostate and Keratin.
His work on Apoptosis is being expanded to include thematically relevant topics such as Shock.
Sepsis is a subfield of Immunology that Paul E. Swanson investigates.
He most often published in these fields:
- Pathology (69.31%)
- Immunohistochemistry (37.62%)
- Carcinoma (11.88%)
What were the highlights of his more recent work (between 2011-2020)?
- Pathology (69.31%)
- Immunohistochemistry (37.62%)
- Medical physics (4.46%)
In recent papers he was focusing on the following fields of study:
Paul E. Swanson focuses on Pathology, Immunohistochemistry, Medical physics, Internal medicine and MEDLINE.
Paul E. Swanson integrates Pathology with Expert committee in his study.
Paul E. Swanson combines subjects such as Staining and Monoclonal with his study of Immunohistochemistry.
His Medical physics research is multidisciplinary, relying on both Precision medicine, Guideline and Tissue sections.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
Paul E. Swanson has researched MEDLINE in several fields, including Sepsis and Intensive care medicine.
Between 2011 and 2020, his most popular works were:
- Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories. (26 citations)
- Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience. (22 citations)
- Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics (21 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
Paul E. Swanson spends much of his time researching Pathology, Immunohistochemistry, Quality assurance, Medical physics and Precision medicine.
All of his Pathology and Fibrous dysplasia and Histology investigations are sub-components of the entire Pathology study.
While working in this field, Paul E. Swanson studies both Immunohistochemistry and Alternative splicing.
Paul E. Swanson integrates many fields in his works, including Quality assurance, MEDLINE and Bioinformatics.
Paul E. Swanson combines topics linked to Biomarker with his work on MEDLINE.
His study in the field of Clinical trial also crosses realms of Test performance, Basic research, Patient safety and Clinical Practice.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
